ANNY EVANS: Open Payments
NPI 1346712791 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 47 payments from 17 companies in 2025. Trend: 2023 $2,374 · 2024 $2,013 · 2025 $970
Food & beverage: $970
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 6 | $135 |
| Otsuka America Pharmaceutical, Inc. | 5 | $117 |
| ACADIA Pharmaceuticals Inc | 5 | $115 |
| ABBVIE INC. | 5 | $95 |
| Lilly USA, LLC | 5 | $81 |
| Eisai Inc. | 3 | $60 |
| PFIZER INC. | 3 | $55 |
| Inspire Medical Systems, Inc. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
Products named: REXULTI, NUPLAZID, QULIPTA, KISUNLA, Leqembi, NURTEC ODT, INSPIRE, KESIMPTA.
Industry payments across MS — which companies pay providers there.
